Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DB25FGS22
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,035
Award facts
- Contract value 100% obligated
- $45,035.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $45,035.05 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Kisqali (ribociclib) 600 mg daily dose in a 63-tablet configuration. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract is set to be completed by April 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kisqali is a cyclin-dependent kinase inhibitor used in oncology treatment, reflecting the Defense Logistics Agency's role in supplying critical pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and the parent company serving as the prime contractor, AmerisourceBergen has demonstrated significant capability in fulfilling federal medical procurement requirements through competitive award processes.
Quick answers
Who was awarded contract SPE2DB25FGS22?
SPE2DB25FGS22 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FGS22 worth?
The government has obligated $45,035 on SPE2DB25FGS22.
Is contract SPE2DB25FGS22 an order under another contract?
Yes. SPE2DB25FGS22 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FGS22 competed?
The extent of competition for SPE2DB25FGS22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award